Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.

This work was consistent with the results that the cytokine‐cytokine receptor response was highly significant in KEGG enrichment, and reported playing an essential role in developing lung cancer. 19 Many drugs targeting various components of TME have been approved for clinical therapy, including aromatase, vascular endothelial growth factor (VEGF), and immune checkpoint inhibitors (ICIs), which gaine

also in 132,142 other papers